Please ensure Javascript is enabled for purposes of website accessibility

Why Guardant Health Stock Is Rising During Today's Market Meltdown

By Keith Speights - Mar 12, 2020 at 12:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some investors appear to be remaining calm in the midst of an overall panic.

What happened

Shares of Guardant Health (GH 4.03%) were rising 8.6% higher as of 1:25 p.m. EDT on Thursday after dropping as much as 11% earlier in the day and later jumping as much as 15.1%. How did the liquid biopsy company manage to defy gravity as the overall stock market plunged on worries about COVID-19? The most likely reason is that investors recognize the pandemic in no way hurts Guardant Health's business prospects.

So what

Very few stocks are rising today in the wake of the market bloodbath. Many of these, like Guardant Health, for all practical purposes have businesses that are immune to the effects of the coronavirus. And yet the stocks are falling nonetheless.

One bright white arrow pointing up with four other arrows pointing down

Image source: Getty Images.

It seems likely that one or more institutional investors have decided to take advantage of Guardant Health's pullback over the last few days to buy the healthcare stock at a discount. Why they're not doing so with other stocks is a mystery. But it's no mystery why Guardant Health would be attractive.

Sales for the company's liquid biopsy products Guardant360 and GuardantOMNI continue to skyrocket. Guardant Health's Lunar assays are waiting in the wings and could be even bigger winners over the long run than its current commercial products. And the prospects for all of these liquid biopsies shouldn't be dented in the slightest by COVID-19.

Now what

Will investors retain their sanity with respect to Guardant Health? Maybe, maybe not. In the current market environment, anything could happen. However, this bright spot on a very dark day for the stock market underscores an important point: There are stocks still worth buying. Guardant Health is definitely one of them.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Guardant Health, Inc. Stock Quote
Guardant Health, Inc.
GH
$46.25 (4.03%) $1.79

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.